RxTrials Institute Drug Pipeline Alert

May 21, 2008 | Vol. 6 No. 21

Generic Heart Drug Dosage Approved

KV Pharmaceutical has received final approval from the FDA of its ANDA to market its 50-mg strength of metoprolol succinate extended-release tablets.

This product is a generic version of AstraZeneca's Toprol-XL.

Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension used alone or in combination with other anti-hypertensive agents for the long-term treatment of angina pectoris, as well as for the treatment of stable, symptomatic heart failure, according to the company.

Register Now
Print This Page
Email This Article
RSS
Archives

Merck Ends Trials For Once-Promising Parkinson’s Drug Novo Nordisk Gearing Up to Double Down on Diabetes Drugs in 2013 Possible FDA Approval of New Pain Drug Using Other Drug’s Data May Save Struggling NeurogesX Drug-Diagnostic Sponsors Must Educate Sites to Avoid Bias That Can Kill Approval

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.